{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T20:51:13Z","timestamp":1776199873542,"version":"3.50.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hallym University Research Fund"},{"name":"The Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology","award":["NRF-2020R1I1A3073530"],"award-info":[{"award-number":["NRF-2020R1I1A3073530"]}]},{"name":"The Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology","award":["NRF-2020R1A6A1A03043026"],"award-info":[{"award-number":["NRF-2020R1A6A1A03043026"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Non-alcoholic fatty liver disease (NAFLD) is a serious public health issue globally, currently, the treatment of NAFLD lies still in the labyrinth. In the inchoate stage, the combinatorial application of food regimen and favorable gut microbiota (GM) are considered as an alternative therapeutic. Accordingly, we integrated secondary metabolites (SMs) from GM and <jats:italic>Avena sativa<\/jats:italic> (AS) known as potent dietary grain to identify the combinatorial efficacy through network pharmacology.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We browsed the SMs of AS via Natural Product Activity &amp; Species Source (NPASS) database and SMs of GM were retrieved by gutMGene database. Then, specific intersecting targets were identified from targets related to SMs of AS and GM. The final targets were selected on NAFLD-related targets, which was considered as crucial targets. The protein\u2013protein interaction (PPI) networks and bubble chart analysis to identify a hub target and a key signaling pathway were conducted, respectively. In parallel, we analyzed the relationship of GM or AS\u2500a key signaling pathway\u2500targets\u2500SMs (GASTM) by merging the five components via RPackage. We identified key SMs on a key signaling pathway via molecular docking assay (MDA). Finally, the identified key SMs were verified the physicochemical properties and toxicity in silico platform.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The final 16 targets were regarded as critical proteins against NAFLD, and Vascular Endothelial Growth Factor A (VEGFA) was a key target in PPI network analysis. The PI3K-Akt signaling pathway was the uppermost mechanism associated with VEGFA as an antagonistic mode. GASTM networks represented 122 nodes (60 GM, AS, PI3K-Akt signaling pathway, 4 targets, and 56 SMs) and 154 edges. The VEGFA-myricetin, or quercetin, GSK3B-myricetin, IL2-diosgenin complexes formed the most stable conformation, the three ligands were derived from GM. Conversely, NR4A1-vestitol formed stable conformation with the highest affinity, and the vestitol was obtained from AS. The given four SMs were no hurdles to develop into drugs devoid of its toxicity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In conclusion, we show that combinatorial application of AS and GM might be exerted to the potent synergistic effects against NAFLD, dampening PI3K-Akt signaling pathway. This work provides the importance of dietary strategy and beneficial GM on NAFLD, a data mining basis for further explicating the SMs and pharmacological mechanisms of combinatorial application (AS and GM) against NAFLD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-023-04122-6","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T19:02:01Z","timestamp":1681758121000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology study"],"prefix":"10.1186","volume":"21","author":[{"given":"Ki-Kwang","family":"Oh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Jun","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Been","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Youn","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haripriya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satya Priya","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Min","family":"Won","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Ju","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki-Tae","family":"Suk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"4122_CR1","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/NU13020494","volume":"13","author":"L Abenavoli","year":"2021","unstructured":"Abenavoli L, Larussa T, Corea A, Procopio AC, Boccuto L, Dallio M, Federico A, Luzza F. Dietary polyphenols and non-alcoholic fatty liver disease. Nutrients. 2021;13:494\u2013503. https:\/\/doi.org\/10.3390\/NU13020494.","journal-title":"Nutrients"},{"key":"4122_CR2","doi-asserted-by":"publisher","DOI":"10.5772\/INTECHOPEN.85780","author":"ZA Sherif","year":"2019","unstructured":"Sherif ZA, Sherif ZA. The rise in the prevalence of nonalcoholic fatty liver disease and hepatocellular carcinoma. Nonalcoholic Fatty Liver Dis An Update. 2019. https:\/\/doi.org\/10.5772\/INTECHOPEN.85780.","journal-title":"Nonalcoholic Fatty Liver Dis An Update"},{"key":"4122_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13098-020-00570-Y\/TABLES\/5","volume":"12","author":"AF Godoy-Matos","year":"2020","unstructured":"Godoy-Matos AF, Silva J\u00fanior WS, Valerio CM. NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. Diabetol Metab Syndr. 2020;12:1\u201320. https:\/\/doi.org\/10.1186\/S13098-020-00570-Y\/TABLES\/5.","journal-title":"Diabetol Metab Syndr"},{"issue":"101215","key":"4122_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.DIABET.2020.101215","volume":"47","author":"G Targher","year":"2021","unstructured":"Targher G, Corey KE, Byrne CD. NAFLD, and cardiovascular and cardiac diseases: factors influencing risk, prediction and treatment. Diabetes Metab. 2021;47(101215):1\u201314. https:\/\/doi.org\/10.1016\/J.DIABET.2020.101215.","journal-title":"Diabetes Metab"},{"key":"4122_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/FPHAR.2020.603926\/BIBTEX","volume":"11","author":"C Peng","year":"2020","unstructured":"Peng C, Stewart AG, Woodman OL, Ritchie RH, Qin CX. Non-Alcoholic steatohepatitis: a review of its mechanism, models and medical treatments. Front Pharmacol. 2020;11:1\u201322. https:\/\/doi.org\/10.3389\/FPHAR.2020.603926\/BIBTEX.","journal-title":"Front Pharmacol"},{"key":"4122_CR6","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.3390\/IJERPH16173011","volume":"16","author":"L Abenavoli","year":"2019","unstructured":"Abenavoli L, Boccuto L, Federico A, Dallio M, Loguercio C, Di Renzo L, De Lorenzo A. Diet and non-alcoholic fatty liver disease: the mediterranean way. Int J Environ Res Public Health. 2019;16:3011\u20139. https:\/\/doi.org\/10.3390\/IJERPH16173011.","journal-title":"Int J Environ Res Public Health"},{"key":"4122_CR7","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.3390\/NU12113472","volume":"12","author":"D Carneros","year":"2020","unstructured":"Carneros D, L\u00f3pez-Lluch G, Bustos M. Physiopathology of lifestyle interventions in non-alcoholic fatty liver disease (NAFLD). Nutrients. 2020;12:3472\u201394. https:\/\/doi.org\/10.3390\/NU12113472.","journal-title":"Nutrients"},{"key":"4122_CR8","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/J.JHEP.2017.05.016","volume":"67","author":"M Romero-G\u00f3mez","year":"2017","unstructured":"Romero-G\u00f3mez M, Zelber-Sagi S, Trenell M. Treatment of NAFLD with diet, physical activity and exercise. J Hepatol. 2017;67:829\u201346. https:\/\/doi.org\/10.1016\/J.JHEP.2017.05.016.","journal-title":"J Hepatol"},{"key":"4122_CR9","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/10408398.2010.526725","volume":"53","author":"R Singh","year":"2012","unstructured":"Singh R, De S, Belkheir A. Avena sativa (Oat), a potential neutraceutical and therapeutic agent: an overview. Critical Rev Food Sci Nutr. 2012;53:126\u201344. https:\/\/doi.org\/10.1080\/10408398.2010.526725.","journal-title":"Critical Rev Food Sci Nutr"},{"key":"4122_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/J.TIFS.2020.12.006","volume":"107","author":"G Zamaratskaia","year":"2021","unstructured":"Zamaratskaia G, Gerhardt K, Wendin K. Biochemical characteristics and potential applications of ancient cereals\u2014an underexploited opportunity for sustainable production and consumption. Trends Food Sci Technol. 2021;107:114\u201323. https:\/\/doi.org\/10.1016\/J.TIFS.2020.12.006.","journal-title":"Trends Food Sci Technol"},{"issue":"5","key":"4122_CR11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/nutrit\/nuz064","volume":"78","author":"R Korczak","year":"2020","unstructured":"Korczak R, Kocher M, Swanson KS. Effects of oats on gastrointestinal health as assessed by in vitro, animal, and human studies. Nutr Rev. 2020;78(5):343\u201363. https:\/\/doi.org\/10.1093\/nutrit\/nuz064.","journal-title":"Nutr Rev"},{"key":"4122_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/2682748","volume":"2019","author":"C Pan","year":"2019","unstructured":"Pan C, Guo Q, Lu N, Dai C. Role of gut microbiota in the pharmacological effects of natural products. Evidence-Based Compl Alter Med eCAM. 2019;2019:1\u20138. https:\/\/doi.org\/10.1155\/2019\/2682748.","journal-title":"Evidence-Based Compl Alter Med eCAM"},{"key":"4122_CR13","doi-asserted-by":"publisher","first-page":"7629","DOI":"10.1021\/ACS.JAFC.1C01813\/ASSET\/IMAGES\/LARGE\/JF1C01813_0007.JPEG","volume":"69","author":"R Duan","year":"2021","unstructured":"Duan R, Guan X, Huang K, Zhang Y, Li S, Xia J, Shen M. Flavonoids from whole-grain oat alleviated high-fat diet-induced hyperlipidemia via regulating bile acid metabolism and gut microbiota in mice. J Agric Food Chem. 2021;69:7629\u201340. https:\/\/doi.org\/10.1021\/ACS.JAFC.1C01813\/ASSET\/IMAGES\/LARGE\/JF1C01813_0007.JPEG.","journal-title":"J Agric Food Chem"},{"key":"4122_CR14","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1016\/J.NUMECD.2021.03.026","volume":"31","author":"J Qin","year":"2021","unstructured":"Qin J, Liu L, Su XD, Wang BB, Fu BS, Cui JZ, Liu XY. The effect of PCSK9 inhibitors on brain stroke prevention: a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2021;31:2234\u201343. https:\/\/doi.org\/10.1016\/J.NUMECD.2021.03.026.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"4122_CR15","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1021\/ACS.JAFC.1C05704","volume":"70","author":"Y Yu","year":"2022","unstructured":"Yu Y, Zhou L, Li X, Liu J, Li H, Gong L, Zhang J, Wang J, Sun B. The progress of nomenclature, structure, metabolism, and bioactivities of oat novel phytochemical: avenanthramides. J Agric Food Chem. 2022;70:446\u201357. https:\/\/doi.org\/10.1021\/ACS.JAFC.1C05704.","journal-title":"J Agric Food Chem"},{"key":"4122_CR16","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3389\/FPHYS.2019.00428\/BIBTEX","volume":"10","author":"AM Martin","year":"2019","unstructured":"Martin AM, Sun EW, Rogers GB, Keating DJ. The influence of the gut microbiome on host metabolism through the regulation of gut hormone release. Front Physiol. 2019;10:428\u201338. https:\/\/doi.org\/10.3389\/FPHYS.2019.00428\/BIBTEX.","journal-title":"Front Physiol"},{"key":"4122_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/IJMS23063167","volume":"23","author":"L Arellano-Garc\u00eda","year":"2022","unstructured":"Arellano-Garc\u00eda L, Portillo MP, Mart\u00ednez JA, Milton-Laskibar I. Usefulness of probiotics in the management of NAFLD: evidence and involved mechanisms of action from preclinical and human models. Int J Mol Sci. 2022;23:1\u201325. https:\/\/doi.org\/10.3390\/IJMS23063167.","journal-title":"Int J Mol Sci"},{"key":"4122_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/J.JNUTBIO.2014.10.016","volume":"26","author":"M Zhang","year":"2015","unstructured":"Zhang M, Wang C, Wang C, Zhao H, Zhao C, Chen Y, Wang Y, McClain C, Feng W. Enhanced AMPK phosphorylation contributes to the beneficial effects of Lactobacillus rhamnosus GG supernatant on chronic-alcohol-induced fatty liver disease. J Nutr Biochem. 2015;26:337\u201344. https:\/\/doi.org\/10.1016\/J.JNUTBIO.2014.10.016.","journal-title":"J Nutr Biochem"},{"key":"4122_CR19","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3920\/BM2019.0058","volume":"10","author":"LC Lew","year":"2019","unstructured":"Lew LC, Hor YY, Jaafar MH, Lau ASY, Ong JS, Chuah LO, Yap KP, Azzam G, Azlan A, Liong MT. Lactobacilli modulated AMPK activity and prevented telomere shortening in ageing rats. Beneficial Microbes. 2019;10:883\u201392. https:\/\/doi.org\/10.3920\/BM2019.0058.","journal-title":"Beneficial Microbes"},{"key":"4122_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/IJMS222413475","volume":"22","author":"R Jastrz\u0105b","year":"2021","unstructured":"Jastrz\u0105b R, Graczyk D, Siedlecki P. Molecular and Cellular Mechanisms Influenced by Postbiotics. Int J Mol Sci. 2021;22:1\u201334. https:\/\/doi.org\/10.3390\/IJMS222413475.","journal-title":"Int J Mol Sci"},{"key":"4122_CR21","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1039\/C5NP00005J","volume":"32","author":"M Kibble","year":"2015","unstructured":"Kibble M, Saarinen N, Tang J, Wennerberg K, M\u00e4kel\u00e4 S, Aittokallio T. Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products. Nat Prod Rep. 2015;32:1249\u201366. https:\/\/doi.org\/10.1039\/C5NP00005J.","journal-title":"Nat Prod Rep"},{"key":"4122_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12906-021-03215-3\/FIGURES\/5","volume":"21","author":"Y Dong","year":"2021","unstructured":"Dong Y, Hao L, Fang K, Han XX, Yu H, Zhang JJ, Cai LJ, Fan T, Zhang WD, Pang K, Ma WM, et al. A network pharmacology perspective for deciphering potential mechanisms of action of Solanum nigrum L. in bladder cancer. BMC Compl Med Ther. 2021;21:1\u201314. https:\/\/doi.org\/10.1186\/S12906-021-03215-3\/FIGURES\/5.","journal-title":"BMC Compl Med Ther"},{"key":"4122_CR23","doi-asserted-by":"publisher","first-page":"7825","DOI":"10.1021\/ACSOMEGA.1C06729\/ASSET\/IMAGES\/LARGE\/AO1C06729_0006.JPEG","volume":"7","author":"SS Wu","year":"2022","unstructured":"Wu SS, Hao LJ, Shi YY, Lu ZJ, Yu JL, Jiang SQ, Liu QL, Wang T, Guo SY, Li P, et al. Network pharmacology-based analysis on the effects and mechanism of the wang-bi capsule for rheumatoid arthritis and osteoarthritis. ACS Omega. 2022;7:7825\u201336. https:\/\/doi.org\/10.1021\/ACSOMEGA.1C06729\/ASSET\/IMAGES\/LARGE\/AO1C06729_0006.JPEG.","journal-title":"ACS Omega"},{"issue":"3330","key":"4122_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/FPHAR.2021.746923\/BIBTEX","volume":"12","author":"Z Zhen","year":"2021","unstructured":"Zhen Z, Xia L, You H, Jingwei Z, Shasha Y, Xinyi W, Wenjing L, Xin Z, Chaomei F. An integrated gut microbiota and network pharmacology study on fuzi-lizhong pill for treating diarrhea-predominant irritable bowel syndrome. Front Pharmacol. 2021;12(3330):1\u201314. https:\/\/doi.org\/10.3389\/FPHAR.2021.746923\/BIBTEX.","journal-title":"Front Pharmacol"},{"key":"4122_CR25","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.3390\/CIMB44070224","volume":"44","author":"KK Oh","year":"2022","unstructured":"Oh KK, Choi YR, Gupta H, Ganesan R, Sharma SP, Won SM, Jeong JJ, Lee SB, Cha MG, Kwon GH, et al. Identification of gut microbiome metabolites via network pharmacology analysis in treating alcoholic liver disease. Curr Issues Mol Biol. 2022;44:3253\u201366. https:\/\/doi.org\/10.3390\/CIMB44070224.","journal-title":"Curr Issues Mol Biol"},{"key":"4122_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/CELLS11182903","volume":"11","author":"KK Oh","year":"2022","unstructured":"Oh KK, Gupta H, Min BH, Ganesan R, Sharma SP, Won SM, Jeong JJ, Lee SB, Cha MG, Kwon GH, et al. Elucidation of prebiotics, probiotics, postbiotics, and target from gut microbiota to alleviate obesity via network pharmacology study. Cells. 2022;11:1\u201314. https:\/\/doi.org\/10.3390\/CELLS11182903.","journal-title":"Cells"},{"key":"4122_CR27","doi-asserted-by":"publisher","first-page":"D1217","DOI":"10.1093\/NAR\/GKX1026","volume":"46","author":"X Zeng","year":"2018","unstructured":"Zeng X, Zhang P, He W, Qin C, Chen S, Tao L, Wang Y, Tan Y, Gao D, Wang B, et al. NPASS: natural product activity and species source database for natural product research, discovery and tool development. Nucleic Acids Res. 2018;46:D1217\u201322. https:\/\/doi.org\/10.1093\/NAR\/GKX1026.","journal-title":"Nucleic Acids Res"},{"key":"4122_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/NBT1284","volume":"25","author":"MJ Keiser","year":"2007","unstructured":"Keiser MJ, Roth BL, Armbruster BN, Ernsberger P, Irwin JJ, Shoichet BK. Relating protein pharmacology by ligand chemistry. Nat Biotechnol. 2007;25:197\u2013206. https:\/\/doi.org\/10.1038\/NBT1284.","journal-title":"Nat Biotechnol"},{"key":"4122_CR29","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/NAR\/GKZ382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina A, Michielin O, Zoete V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 2019;47:W357\u20133664. https:\/\/doi.org\/10.1093\/NAR\/GKZ382.","journal-title":"Nucleic Acids Res"},{"key":"4122_CR30","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1093\/BIB\/BBAA034","volume":"22","author":"N Singh","year":"2021","unstructured":"Singh N, Chaput L, Villoutreix BO. Virtual screening web servers: designing chemical probes and drug candidates in the cyberspace. Brief Bioinform. 2021;22:1790\u2013818. https:\/\/doi.org\/10.1093\/BIB\/BBAA034.","journal-title":"Brief Bioinform"},{"key":"4122_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/JOURNAL.PONE.0170551\/PONE_0170551_PDF.PDF","volume":"12","author":"HC Soo","year":"2017","unstructured":"Soo HC, Chung FFL, Lim KH, Yap VA, Bradshaw TD, Hii LW, Tan SH, See SJ, Tan YF, Leong CO, et al. Cudraflavone C induces tumor-specific apoptosis in colorectal cancer cells through inhibition of the phosphoinositide 3-kinase (PI3K)-AKT pathway. PLoS ONE. 2017;12:1\u201320. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0170551\/PONE_0170551_PDF.PDF.","journal-title":"PLoS ONE"},{"key":"4122_CR32","doi-asserted-by":"publisher","first-page":"D795","DOI":"10.1093\/NAR\/GKAB786","volume":"50","author":"L Cheng","year":"2022","unstructured":"Cheng L, Qi C, Yang H, Lu M, Cai Y, Fu T, Ren J, Jin Q, Zhang X. gutMGene: a comprehensive database for target genes of gut microbes and microbial metabolites. Nucleic Acids Res. 2022;50:D795\u2013800. https:\/\/doi.org\/10.1093\/NAR\/GKAB786.","journal-title":"Nucleic Acids Res"},{"key":"4122_CR33","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1016\/J.CSBJ.2021.05.015","volume":"19","author":"J Pi\u00f1ero","year":"2021","unstructured":"Pi\u00f1ero J, Sa\u00fcch J, Sanz F, Furlong LI. The DisGeNET cytoscape app: exploring and visualizing disease genomics data. Comput Struct Biotechnol J. 2021;19:2960\u20137. https:\/\/doi.org\/10.1016\/J.CSBJ.2021.05.015.","journal-title":"Comput Struct Biotechnol J"},{"key":"4122_CR34","doi-asserted-by":"publisher","first-page":"D789","DOI":"10.1093\/NAR\/GKU1205","volume":"43","author":"JS Amberger","year":"2015","unstructured":"Amberger JS, Bocchini CA, Schiettecatte F, Scott AF, Hamosh A. OMIM.org: Online Mendelian Inheritance in Man (OMIM\u00ae), an online catalog of human genes and genetic disorders. Nucleic Acids Res. 2015;43:D789\u201398. https:\/\/doi.org\/10.1093\/NAR\/GKU1205.","journal-title":"Nucleic Acids Res"},{"key":"4122_CR35","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/NAR\/GKAA1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, Doncheva NT, Legeay M, Fang T, Bork P, et al. The STRING database in 2021: customizable protein\u2013protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 2021;49:D605\u201312. https:\/\/doi.org\/10.1093\/NAR\/GKAA1074.","journal-title":"Nucleic Acids Res"},{"key":"4122_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/AABC.S63749","volume":"7","author":"S Shityakov","year":"2014","unstructured":"Shityakov S, F\u00f6rster C. In silico predictive model to determine vector-mediated transport properties for the blood-brain barrier choline transporter. Adv Appl Bioinform Chem AABC. 2014;7:23\u201336. https:\/\/doi.org\/10.2147\/AABC.S63749.","journal-title":"Adv Appl Bioinform Chem AABC"},{"key":"4122_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:1\u201313. https:\/\/doi.org\/10.1038\/srep42717.","journal-title":"Sci Rep"},{"key":"4122_CR38","doi-asserted-by":"publisher","first-page":"W5","DOI":"10.1093\/NAR\/GKAB255","volume":"49","author":"G Xiong","year":"2021","unstructured":"Xiong G, Wu Z, Yi J, Fu L, Yang Z, Hsieh C, Yin M, Zeng X, Wu C, Lu A, et al. ADMETlab 2 0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res. 2021;49:W5\u201314. https:\/\/doi.org\/10.1093\/NAR\/GKAB255.","journal-title":"Nucleic Acids Res"},{"key":"4122_CR39","doi-asserted-by":"publisher","first-page":"W257","DOI":"10.1093\/NAR\/GKY318","volume":"46","author":"P Banerjee","year":"2018","unstructured":"Banerjee P, Eckert AO, Schrey AK, Preissner R. ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 2018;46:W257\u201363. https:\/\/doi.org\/10.1093\/NAR\/GKY318.","journal-title":"Nucleic Acids Res"},{"key":"4122_CR40","doi-asserted-by":"publisher","first-page":"20387","DOI":"10.1074\/JBC.M116.743138","volume":"291","author":"SM Lamothe","year":"2016","unstructured":"Lamothe SM, Guo J, Li W, Yang T, Zhang S. The human Ether-a-go-go-related Gene (hERG) potassium channel represents an unusual target for protease-mediated damage. J Biol Chem. 2016;291:20387\u2013401. https:\/\/doi.org\/10.1074\/JBC.M116.743138.","journal-title":"J Biol Chem"},{"key":"4122_CR41","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1021\/ACS.CHEMRESTOX.5B00465\/SUPPL_FILE\/TX5B00465_SI_003.ZIP","volume":"29","author":"D Mulliner","year":"2016","unstructured":"Mulliner D, Schmidt F, Stolte M, Spirkl HP, Czich A, Amberg A. Computational models for human and animal hepatotoxicity with a global application scope. Chem Res Toxicol. 2016;29:757\u201367. https:\/\/doi.org\/10.1021\/ACS.CHEMRESTOX.5B00465\/SUPPL_FILE\/TX5B00465_SI_003.ZIP.","journal-title":"Chem Res Toxicol"},{"key":"4122_CR42","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.yrtph.2004.11.001","volume":"41","author":"DW Gaylor","year":"2005","unstructured":"Gaylor DW. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens? Regul Toxicol Pharmacol. 2005;41:128\u201333. https:\/\/doi.org\/10.1016\/j.yrtph.2004.11.001.","journal-title":"Regul Toxicol Pharmacol"},{"key":"4122_CR43","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1517\/17460441.3.6.655","volume":"3","author":"AL Niles","year":"2008","unstructured":"Niles AL, Moravec RA, Riss TL. Update on in vitro cytotoxicity assays for drug development. Expert Opin Drug Discov. 2008;3:655\u201369. https:\/\/doi.org\/10.1517\/17460441.3.6.655.","journal-title":"Expert Opin Drug Discov"},{"issue":"2","key":"4122_CR44","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/15569527.2021.1910291","volume":"40","author":"AJ Clippinger","year":"2021","unstructured":"Clippinger AJ, Raabe HA, Allen DG, Choksi NY, Van Der Zalm AJ, Kleinstreuer NC, Barroso J, Lowit AB, Ao Barroso J. Human-relevant approaches to assess eye corrosion\/irritation potential of agrochemical formulations Human-relevant approaches to assess eye corrosion\/irritation potential of agrochemical formulations. Cutaneous Ocular Toxicol. 2021;40(2):145\u201367. https:\/\/doi.org\/10.1080\/15569527.2021.1910291.","journal-title":"Cutaneous Ocular Toxicol"},{"key":"4122_CR45","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1517\/17425255.2014.918954","volume":"10","author":"LY Du","year":"2014","unstructured":"Du LY, Zhao M, Xu J, Qian DW, Jiang S, Shang EX, Guo JM, Liu P, Su SL, Duan JA, et al. Identification of the metabolites of myricitrin produced by human intestinal bacteria in vitro using ultra-performance liquid chromatography\/quadrupole time-of-flight mass spectrometry. Expert Opin Drug Metab Toxicol. 2014;10:921\u201331. https:\/\/doi.org\/10.1517\/17425255.2014.918954.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"4122_CR46","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/S12272-013-0172-9","volume":"37","author":"S Jiang","year":"2014","unstructured":"Jiang S, Yang J, Qian D, Guo J, Shang EX, Duan JA, Xu J. Rapid screening and identification of metabolites of quercitrin produced by the human intestinal bacteria using ultra performance liquid chromatography\/quadrupole-time-of-flight mass spectrometry. Arch Pharmacal Res. 2014;37:204\u201313. https:\/\/doi.org\/10.1007\/S12272-013-0172-9.","journal-title":"Arch Pharmacal Res"},{"key":"4122_CR47","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4014\/JMB.1404.04060","volume":"25","author":"SH Bang","year":"2015","unstructured":"Bang SH, Hyun YJ, Shim J, Hong SW, Kim DH. Metabolism of rutin and poncirin by human intestinal microbiota and cloning of their metabolizing \u03b1-L-rhamnosidase from Bifidobacterium dentium. J Microbiol Biotechnol. 2015;25:18\u201325. https:\/\/doi.org\/10.4014\/JMB.1404.04060.","journal-title":"J Microbiol Biotechnol"},{"key":"4122_CR48","doi-asserted-by":"publisher","first-page":"6485","DOI":"10.1021\/JF902107D","volume":"57","author":"MV Selma","year":"2009","unstructured":"Selma MV, Esp\u00edn JC, Tom\u00e1s-Barber\u00e1n FA. Interaction between phenolics and gut microbiota: role in human health. J Agric Food Chem. 2009;57:6485\u2013501. https:\/\/doi.org\/10.1021\/JF902107D.","journal-title":"J Agric Food Chem"},{"key":"4122_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/J.JCHROMB.2014.01.005","author":"M Zhao","year":"2014","unstructured":"Zhao M, Jun X, Qian D, Guo J, Jiang S, Shang E-x, Duan J-a, Yang J, Le-yue D. Ultra performance liquid chromatography\/quadrupole-time-of-flight mass spectrometry for determination of avicularin metabolites produced by a human intestinal bacterium. J Chromatography B. 2014. https:\/\/doi.org\/10.1016\/J.JCHROMB.2014.01.005.","journal-title":"J Chromatography B"},{"key":"4122_CR50","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1024\/0300-9831.73.2.79","volume":"73","author":"M Blaut","year":"2003","unstructured":"Blaut M, Schoefer L, Braune A. Transformation of flavonoids by intestinal microorganisms. Int J Vitamin Nut Res. 2003;73:79\u201387. https:\/\/doi.org\/10.1024\/0300-9831.73.2.79.","journal-title":"Int J Vitamin Nut Res"},{"key":"4122_CR51","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3892\/MMR.2019.10241\/HTML","volume":"20","author":"YJ Zhang","year":"2019","unstructured":"Zhang YJ, Sun YZ, Gao XH, Qi RQ. Integrated bioinformatic analysis of differentially expressed genes and signaling pathways in plaque psoriasis. Mol Med Rep. 2019;20:225\u201335. https:\/\/doi.org\/10.3892\/MMR.2019.10241\/HTML.","journal-title":"Mol Med Rep"},{"key":"4122_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/4176518","volume":"2017","author":"JF Feng","year":"2017","unstructured":"Feng JF, Tang YN, Ji H, Xiao ZG, Zhu L, Yi T. Biotransformation of dioscorea nipponica by rat intestinal microflora and cardioprotective effects of diosgenin. Oxid Med Cell Longev. 2017;2017:1\u20139. https:\/\/doi.org\/10.1155\/2017\/4176518.","journal-title":"Oxid Med Cell Longev"},{"issue":"109641","key":"4122_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.CELREP.2021.109641","volume":"36","author":"WL Sun","year":"2021","unstructured":"Sun WL, Li XY, Dou HY, Wang XD, Li J, Da; Shen, L., Ji, H.F. Myricetin supplementation decreases hepatic lipid synthesis and inflammation by modulating gut microbiota. Cell Rep. 2021;36(109641):1\u201319. https:\/\/doi.org\/10.1016\/J.CELREP.2021.109641.","journal-title":"Cell Rep"},{"key":"4122_CR54","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1002\/PTR.6486","volume":"33","author":"H Yang","year":"2019","unstructured":"Yang H, Yang T, Heng C, Zhou Y, Jiang Z, Qian X, Du L, Mao S, Yin X, Lu Q. Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db\/db mice. Phytotherapy Res PTR. 2019;33:3140\u201352. https:\/\/doi.org\/10.1002\/PTR.6486.","journal-title":"Phytotherapy Res PTR"},{"key":"4122_CR55","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.2337\/DB13-1665","volume":"63","author":"LE Wu","year":"2014","unstructured":"Wu LE, Meoli CC, Mangiafico SP, Fazakerley DJ, Cogger VC, Mohamad M, Pant H, Kang MJ, Powter E, Burchfield JG, et al. Systemic VEGF-A neutralization ameliorates diet-induced metabolic dysfunction. Diabetes. 2014;63:2656\u201367. https:\/\/doi.org\/10.2337\/DB13-1665.","journal-title":"Diabetes"},{"key":"4122_CR56","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.2147\/DDDT.S368836","volume":"16","author":"D Wang","year":"2022","unstructured":"Wang D, Wang X. Diosgenin and its analogs: potential protective agents against atherosclerosis. Drug Des Dev Ther. 2022;16:2305\u201323. https:\/\/doi.org\/10.2147\/DDDT.S368836.","journal-title":"Drug Des Dev Ther"},{"key":"4122_CR57","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3177\/JNSV.65.421","volume":"65","author":"Y Kusano","year":"2019","unstructured":"Kusano Y, Tsujihara N, Masui H, Shibata T, Uchida K, Takeuchi W. Diosgenin supplementation prevents lipid accumulation and induces skeletal muscle-fiber hypertrophy in rats. J Nutr Sci Vitaminol. 2019;65:421\u20139. https:\/\/doi.org\/10.3177\/JNSV.65.421.","journal-title":"J Nutr Sci Vitaminol"},{"key":"4122_CR58","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.2147\/DMSO.S326054","volume":"14","author":"F Sun","year":"2021","unstructured":"Sun F, Yang X, Ma C, Zhang S, Yu L, Lu H, Yin G, Liang P, Feng Y, Zhang F. <p>The effects of diosgenin on hypolipidemia and its underlying mechanism: a review<\/p>. Diabetes Metab Syn Obesity Targets Ther. 2021;14:4015\u201330. https:\/\/doi.org\/10.2147\/DMSO.S326054.","journal-title":"Diabetes Metab Syn Obesity Targets Ther"},{"key":"4122_CR59","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/J.EJPS.2012.07.013","volume":"47","author":"M Kaur","year":"2012","unstructured":"Kaur M, Bahia MS, Silakari O. Inhibitors of interleukin-2 inducible T-cell kinase as potential therapeutic candidates for the treatment of various inflammatory disease conditions. Eur J Pharm Sci. 2012;47:574\u201388. https:\/\/doi.org\/10.1016\/J.EJPS.2012.07.013.","journal-title":"Eur J Pharm Sci"},{"key":"4122_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/FIMMU.2022.880298\/FULL","volume":"13","author":"Y Duan","year":"2022","unstructured":"Duan Y, Pan X, Luo J, Xiao X, Li J, Bestman PL, Luo M. Association of inflammatory cytokines with non-alcoholic fatty liver disease. Front Immunol. 2022;13:1\u201315. https:\/\/doi.org\/10.3389\/FIMMU.2022.880298\/FULL.","journal-title":"Front Immunol"},{"key":"4122_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/NU8020090","volume":"8","author":"DK Semwal","year":"2016","unstructured":"Semwal DK, Semwal RB, Combrinck S, Viljoen A. Myricetin: a dietary molecule with diverse biological activities. Nutrients. 2016;8:1\u201331. https:\/\/doi.org\/10.3390\/NU8020090.","journal-title":"Nutrients"},{"issue":"102149","key":"4122_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.ISCI.2021.102149","volume":"24","author":"Y Li","year":"2021","unstructured":"Li Y, Lin Y, Han X, Li W, Yan W, Ma Y, Lu X, Huang X, Bai R, Zhang H. GSK3 inhibitor ameliorates steatosis through the modulation of mitochondrial dysfunction in hepatocytes of obese patients. iScience. 2021;24(102149):1\u201350. https:\/\/doi.org\/10.1016\/J.ISCI.2021.102149.","journal-title":"iScience"},{"key":"4122_CR63","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/S10620-013-2896-2","volume":"59","author":"J Cao","year":"2014","unstructured":"Cao J, Feng XX, Yao L, Ning B, Yang ZX, Fang DL, Shen W. Saturated free fatty acid sodium palmitate-induced lipoapoptosis by targeting glycogen synthase kinase-3\u03b2 activation in human liver cells. Dig Dis Sci. 2014;59:346\u201357. https:\/\/doi.org\/10.1007\/S10620-013-2896-2.","journal-title":"Dig Dis Sci"},{"key":"4122_CR64","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1021\/ACS.JNATPROD.5B00938\/ASSET\/IMAGES\/MEDIUM\/NP-2015-00938K_0008.GIF","volume":"79","author":"M Franchin","year":"2016","unstructured":"Franchin M, C\u00f3lon DF, Castanheira FVS, Da Cunha MG, Bueno-Silva B, Alencar SM, Cunha TM, Rosalen PL. Vestitol isolated from brazilian red propolis inhibits neutrophils migration in the inflammatory process: elucidation of the mechanism of action. J Nat Prod. 2016;79:954\u201360. https:\/\/doi.org\/10.1021\/ACS.JNATPROD.5B00938\/ASSET\/IMAGES\/MEDIUM\/NP-2015-00938K_0008.GIF.","journal-title":"J Nat Prod"},{"key":"4122_CR65","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.3892\/ETM.2014.1958\/HTML","volume":"8","author":"Q Huang","year":"2014","unstructured":"Huang Q, Xue J, Zou R, Cai L, Chen J, Sun L, Dai Z, Yang F, Xu Y. NR4A1 is associated with chronic Low-Grade inflammation in patients with type 2 diabetes. Exp Ther Med. 2014;8:1648\u201354. https:\/\/doi.org\/10.3892\/ETM.2014.1958\/HTML.","journal-title":"Exp Ther Med"},{"key":"4122_CR66","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.jhep.2018.01.035","volume":"68","author":"P Zhang","year":"2018","unstructured":"Zhang P, Ge Z, Wang H, Feng W, Sun X, Chu X, Jiang C, Wang Y, Zhu D, Bi Y. Prolactin improves hepatic steatosis via CD36 pathway. J Hepatol. 2018;68:1247\u201355. https:\/\/doi.org\/10.1016\/j.jhep.2018.01.035.","journal-title":"J Hepatol"},{"key":"4122_CR67","doi-asserted-by":"publisher","first-page":"G211","DOI":"10.1152\/AJPGI.00040.2019","volume":"318","author":"DA Breuer","year":"2020","unstructured":"Breuer DA, Pacheco MC, Washington MK, Montgomery SA, Hasty AH, Kennedy AJ. CD8+ T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease. Am J Physiol Gastroin Liver Physiol. 2020;318:G211\u201324. https:\/\/doi.org\/10.1152\/AJPGI.00040.2019.","journal-title":"Am J Physiol Gastroin Liver Physiol"},{"key":"4122_CR68","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/NATURE16969","volume":"531","author":"C Ma","year":"2016","unstructured":"Ma C, Kesarwala AH, Eggert T, Medina-Echeverz J, Kleiner DE, Jin P, Stroncek DF, Terabe M, Kapoor V, ElGindi M, et al. NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis. Nature. 2016;531:253\u20137. https:\/\/doi.org\/10.1038\/NATURE16969.","journal-title":"Nature"},{"key":"4122_CR69","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/J.CLNU.2020.04.033","volume":"40","author":"H Coia","year":"2021","unstructured":"Coia H, Ma N, Hou Y, Permaul E, Berry DL, Cruz MI, Pannkuk E, Girgis M, Zhu Z, Lee Y, et al. Theaphenon E prevents fatty liver disease and increases CD4+ T cell survival in mice fed a high-fat diet. Clin Nutrition. 2021;40:110\u20139. https:\/\/doi.org\/10.1016\/J.CLNU.2020.04.033.","journal-title":"Clin Nutrition"},{"key":"4122_CR70","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/NATURE16969","volume":"531","author":"C Ma","year":"2016","unstructured":"Ma C, Kesarwala AH, Eggert T, Medina-Echeverz J, Kleiner DE, Jin P, Stroncek DF, Terabe M, Kapoor V, ElGindi M, et al. NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis. Nature. 2016;531:253\u20137. https:\/\/doi.org\/10.1038\/NATURE16969.","journal-title":"Nature"},{"key":"4122_CR71","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.7150\/IJBS.27173","volume":"14","author":"X Huang","year":"2018","unstructured":"Huang X, Liu G, Guo J, Su ZQ. The PI3K\/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci. 2018;14:1483\u201396. https:\/\/doi.org\/10.7150\/IJBS.27173.","journal-title":"Int J Biol Sci"},{"key":"4122_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/472432","volume":"2013","author":"S Matsuda","year":"2013","unstructured":"Matsuda S, Kobayashi M, Kitagishi Y. Roles for PI3K\/AKT\/PTEN pathway in cell signaling of nonalcoholic fatty liver disease. ISRN Endocrinol. 2013;2013:1\u20137. https:\/\/doi.org\/10.1155\/2013\/472432.","journal-title":"ISRN Endocrinol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04122-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04122-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04122-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T19:03:49Z","timestamp":1681758229000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04122-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4122"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04122-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"assertion":[{"value":"6 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There is no conflict of interest declared.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"263"}}